查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574984

慢性病管理市场，按平台类型、服务类型、疾病类型、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Chronic Disease Management Market, By Platform Type, By Service Type, By Disease Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年慢性病管理市场规模为51.0932亿美元，2024年至2032年复合年增长率为14.90%。

慢性病管理市场-市场动态

对预防性医疗保健的日益重视推动了慢性病管理市场的扩大

随着组织和政府越来越认识到早期介入和持续照护的重要性，对预防性医疗保健的日益重视正在显着推动慢性病管理市场的扩张。根据美国疾病管制与预防中心 (CDC) 的数据，慢性病占美国 10 大死因中的 7 个，凸显了有效管理策略的迫切需求。美国国立卫生研究院的一项研究发现，生活方式的改变和预防措施可以将慢性病的风险降低80%。此外，世界卫生组织全球行动计画等措施的目标是到 2025 年将非传染性疾病造成的过早死亡率降低 25%，这强化了以预防为重点的全面慢性病管理计画的必要性。

慢性病管理市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 14.90% 左右的复合年增长率成长

根据平台类型细分，预计基于云端的解决方案将在 2023 年显示最大的市场份额

根据服务类型细分，2023年护理协调为主导类型

依疾病类型细分，2023年心血管疾病为主导类型

按地区划分，北美是 2023 年的主要收入来源

慢性病管理市场-細項分析：

全球慢性病管理市场根据平台类型、服务类型、疾病类型、最终用户和地区进行细分。

根据平台类型，市场分为三类：基于网路的解决方案、基于云端的解决方案和本地解决方案。基于云端的解决方案因其可扩展性和可访问性而受到欢迎，其次是基于网路的解决方案，为患者和提供者提供用户友好的介面。本地解决方案排名第三，主要由大型医疗机构用于资料安全。

根据服务类型，市场分为四个类别：咨询、护理协调、教育和培训以及监测和评估。护理协调服务因其在患者管理中的关键作用而被优先考虑，其次是确保持续评估的监测和评估服务。咨询排名第三，而教育和培训服务对于增强患者能力至关重要。

慢性病管理市场-地理洞察

慢性病管理市场呈现多样化的地理动态，在高医疗保健支出和先进基础设施的推动下，北美处于领先地位。在美国，疾病预防控制中心的国家糖尿病预防计画等措施已成功地将参与者的糖尿病发生率降低了 58%。欧洲紧随其后，德国和英国等国家正在优先考虑综合护理模式以有效管理慢性病，NHS 对糖尿病管理计划的承诺证明了这一点，该计划旨在改善超过 100 万名患者的治疗结果。在意识不断提高和老年人口不断增加的推动下，亚太地区正在迅速崛起；例如，日本厚生劳动省实施了一项独特的健康管理倡议，针对肥胖和代谢综合征，以对抗慢性病。在拉丁美洲，巴西正在努力建立更具预防性的医疗保健模式，重点是解决高血压和糖尿病问题的公共卫生运动。最后，中东和非洲对医疗保健技术的投资不断增加，旨在透过远距医疗服务和社区健康计画加强慢性病管理。

慢性病管理市场-竞争格局：

慢性病管理市场的竞争格局是由各个地区的主要参与者塑造的，每个参与者都积极致力于改善病患照护。北美仍处于领先地位，联合健康集团和信诺等公司投资于创新的数位健康平台，以简化慢性病管理； CMS 长期照护管理计划等措施已成功招募了超过 30 万名医疗保险受益人，以改善照护协调。在欧洲，拜耳和赛诺菲等主要参与者在欧盟卫生倡议的支持下重点关注综合护理模式，该倡议旨在到2025 年将慢性病患病率降低20%。推出了远距医疗服务，在澳洲等国家，疫情期间使用量增加了 140%。拉丁美洲也正在兴起，巴西的「Saude na Hora」等措施旨在为服务不足的社区提供可及的慢性病管理服务。同时，在西门子医疗等公司的推动下，中东和非洲对医疗保健技术的投资不断增加，从而增强了该地区获得医疗服务的机会并改善了管理策略。

最新进展：

2024 年 1 月，亚马逊与 Omada Health 合作推出了一项慢性病管理计划，为使用者提供糖尿病和体重管理服务。该计划旨在帮助消费者透过亚马逊平台获得符合资格的福利，提高医疗保健的可近性

2022 年 2 月，Teladoc Health 推出了慢性护理完整计划，针对糖尿病、糖尿病前期和高血压管理。该计划包括连网设备、个人健康教练和心理健康支持，可透过健康计划或雇主提供，以加强患者护理和管理。

目录

第一章：慢性病管理市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按平台类型分類的慢性病管理市场片段
    • 按服务类型分類的慢性病管理市场片段
    • 按疾病类型分類的慢性病管理市场片段
    • 最终使用者的慢性病管理市场片段
    • 按国家/地区分類的慢性病管理市场片段
    • 按地区分類的慢性病管理市场片段
  • 竞争洞察

第 3 章：慢性病管理主要市场趋势

  • 慢性病管理市场驱动因素
    • 市场驱动因素的影响分析
  • 慢性病管理市场限制
    • 市场限制影响分析
  • 慢性病管理市场机会
  • 慢性病管理市场未来趋势

第四章：慢病管理产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：慢性病管理市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：慢性病管理市场格局

  • 2023 年慢性病管理市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：慢性病管理市场 - 依平台类型

  • 概述
    • 按平台类型分類的细分市场份额分析
    • 网路为基础的解决方案
    • 基于云端的解决方案
    • 本地解决方案

第 8 章：慢性病管理市场 - 按服务类型

  • 概述
    • 按服务类型分類的细分市场占有率分析
    • 咨询
    • 护理协调
    • 教育与培训
    • 监测与评估

第 9 章：慢性病管理市场 - 按疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 糖尿病
    • 心血管疾病
    • 呼吸系统疾病
    • 癌症
    • 其他的

第 10 章：慢性病管理市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 居家护理
    • 诊断中心
    • 付款人

第 11 章：慢性病管理市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美慢性病管理主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按平台类型）
    • 北美市场规模和预测（按服务类型）
    • 北美市场规模和预测（按疾病类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲慢性病管理主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按平台类型）
    • 欧洲市场规模和预测（按服务类型）
    • 欧洲市场规模与预测（按疾病类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区慢性病管理主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依平台类型）
    • 亚太地区市场规模与预测（按服务类型）
    • 亚太地区市场规模与预测（按疾病类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲慢性病管理主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按平台类型）
    • 拉丁美洲市场规模和预测（按服务类型）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲慢性病管理主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按平台类型）
    • 中东和非洲市场规模及预测（按服务类型）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第12章：主要供应商分析-慢性病管理产业

  • 竞争仪表板
  • 公司简介
    • Allscripts Healthcare Solutions, Inc.
    • Altruista Health, Inc.
    • Cerner Corporation
    • Cognizant Technology Solutions Corporation
    • Epic Systems Corporation
    • GE Healthcare
    • Health Catalyst, Inc.
    • i2i Population Health
    • IBM Corporation
    • Infosys Limited
    • Koninklijke Philips NV
    • McKesson Corporation
    • Medtronic plc
    • Pegasystems Inc.
    • Siemens Healthineers AG
    • ZeOmega, Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3993

REPORT HIGHLIGHT

Chronic Disease Management Market size was valued at USD 5,109.32 Million in 2023, expanding at a CAGR of 14.90% from 2024 to 2032.

The Chronic Disease Management Market encompasses various strategies and technologies designed to improve health outcomes for individuals with chronic conditions. Chronic disease management involves the ongoing care and support of patients with long-term illnesses like diabetes, hypertension, and heart disease, with approximately 60% of adults in the U.S. living with at least one chronic condition. Rising healthcare costs, an aging population, and increasing awareness about preventive healthcare are significant factors propelling the demand for chronic disease management solutions. However, challenges such as high implementation costs, lack of skilled professionals, and patient non-compliance can hinder market growth. On the flip side, opportunities abound in the form of advancements in telemedicine, the growing integration of artificial intelligence in healthcare, and the increasing focus on personalized medicine, which can enhance the effectiveness of chronic disease management programs and improve patient adherence.

Chronic Disease Management Market- Market Dynamics

Growing Emphasis on Preventive Healthcare Fuels Expansion of the Chronic Disease Management Market

The growing emphasis on preventive healthcare is significantly driving the expansion of the Chronic Disease Management Market, as organizations and governments increasingly recognize the importance of early intervention and ongoing care. According to the Centers for Disease Control and Prevention (CDC), chronic diseases account for 7 of the 10 leading causes of death in the United States, highlighting the urgent need for effective management strategies. A study by the National Institute of Health found that lifestyle changes and preventive measures could reduce the risk of developing chronic diseases by 80%. Furthermore, initiatives like the World Health Organization's Global Action Plan aim to reduce premature mortality from non-communicable diseases by 25% by 2025, reinforcing the necessity for comprehensive chronic disease management programs that focus on prevention.

Chronic Disease Management Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.90% over the forecast period (2024-2032)

Based on Platform Type segmentation, Cloud-based solutions was predicted to show maximum market share in the year 2023

Based on Service Type segmentation, Care coordination was the leading type in 2023

Based on Disease Type segmentation, cardiovascular diseases was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Chronic Disease Management Market- Segmentation Analysis:

The Global Chronic Disease Management Market is segmented on the basis of Platform Type, Service Type, Disease Type, End-User, and Region.

The market is divided into three categories based on Platform Type: Web-Based Solutions, Cloud-Based Solutions, and On-Premise Solutions. Cloud-based solutions lead in popularity due to their scalability and accessibility, followed by web-based solutions that offer user-friendly interfaces for patients and providers. On-premise solutions rank third, primarily used by large healthcare organizations for data security.

The market is divided into Four categories based on Service Type: Consulting, Care Coordination, Education & Training, and Monitoring & Assessment. Care coordination services are prioritized for their critical role in patient management, followed by monitoring and assessment services that ensure ongoing evaluation. Consulting ranks third, while education and training services are essential for empowering patients.

Chronic Disease Management Market- Geographical Insights

The Chronic Disease Management Market exhibits diverse geographical dynamics, with North America leading the charge, driven by high healthcare expenditure and advanced infrastructure. In the U.S., initiatives like the CDC's National Diabetes Prevention Program have successfully reduced diabetes incidence among participants by 58%. Europe follows closely, where countries like Germany and the UK are prioritizing integrated care models to manage chronic diseases effectively, as evidenced by the NHS's commitment to diabetes management programs, which aim to improve outcomes for over 1 million patients. The Asia-Pacific region is rapidly emerging, fueled by rising awareness and a growing elderly population; for instance, Japan's health ministry has implemented a unique health management initiative targeting obesity and metabolic syndrome to combat chronic diseases. In Latin America, Brazil is working towards a more preventive healthcare model, focusing on public health campaigns to address hypertension and diabetes. Lastly, the Middle East and Africa are seeing increasing investment in healthcare technology, with initiatives aimed at enhancing chronic disease management through telehealth services and community health programs.

Chronic Disease Management Market- Competitive Landscape:

The competitive landscape of the Chronic Disease Management Market is shaped by key players across various regions, each actively working to enhance patient care. North America remains a leader, with companies like UnitedHealth Group and Cigna investing in innovative digital health platforms to streamline chronic disease management; initiatives such as the CMS Chronic Care Management program have successfully enrolled over 300,000 Medicare beneficiaries to improve care coordination. In Europe, major players like Bayer and Sanofi focus on comprehensive care models, supported by EU health initiatives aimed at reducing chronic disease prevalence by 20% by 2025. The Asia-Pacific region is witnessing rapid growth, with organizations like Philips launching telehealth services that increased by 140% in usage during the pandemic in countries like Australia. Latin America is also emerging, with initiatives such as Brazil's "Saude na Hora," which aims to provide accessible chronic disease management services across underserved communities. Meanwhile, the Middle East and Africa see increasing investments in healthcare technology, driven by firms like Siemens Healthineers, enhancing access to care and improving management strategies in the region.

Recent Developments:

In January 2024, Amazon launched a chronic condition management program in partnership with Omada Health, connecting users to services for diabetes and weight management. The initiative aims to help consumers access eligible benefits through Amazon's platform, enhancing healthcare accessibility

In February 2022, Teladoc Health launched its Chronic Care Complete program, targeting diabetes, prediabetes, and hypertension management. The initiative includes connected devices, personal health coaches, and mental health support, available through health plans or employers to enhance patient care and management.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Allscripts Healthcare Solutions, Inc.
  • Altruista Health, Inc.
  • Cerner Corporation
  • Cognizant Technology Solutions Corporation
  • Epic Systems Corporation
  • GE Healthcare
  • Health Catalyst, Inc.
  • i2i Population Health
  • IBM Corporation
  • Infosys Limited
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Medtronic plc
  • Pegasystems Inc.
  • Siemens Healthineers AG
  • ZeOmega, Inc.
  • Others

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY PLATFORM TYPE- MARKET ANALYSIS, 2019 - 2032

  • Web-Based Solutions
  • Cloud-Based Solutions
  • On-Premise Solutions

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Consulting
  • Care Coordination
  • Education & Training
  • Monitoring & Assessment

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Diabetes
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Cancer
  • Others

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Homecare
  • Diagnostic Centers
  • Payers

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Chronic Disease Management Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Chronic Disease Management Market Snippet by Platform Type
    • 2.1.2. Chronic Disease Management Market Snippet by Service Type
    • 2.1.3. Chronic Disease Management Market Snippet by Disease Type
    • 2.1.4. Chronic Disease Management Market Snippet by End-User
    • 2.1.5. Chronic Disease Management Market Snippet by Country
    • 2.1.6. Chronic Disease Management Market Snippet by Region
  • 2.2. Competitive Insights

3. Chronic Disease Management Key Market Trends

  • 3.1. Chronic Disease Management Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Chronic Disease Management Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Chronic Disease Management Market Opportunities
  • 3.4. Chronic Disease Management Market Future Trends

4. Chronic Disease Management Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Chronic Disease Management Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Chronic Disease Management Market Landscape

  • 6.1. Chronic Disease Management Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Chronic Disease Management Market - By Platform Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Platform Type, 2023 & 2032 (%)
    • 7.1.2. Web-Based Solutions
    • 7.1.3. Cloud-Based Solutions
    • 7.1.4. On-Premise Solutions

8. Chronic Disease Management Market - By Service Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
    • 8.1.2. Consulting
    • 8.1.3. Care Coordination
    • 8.1.4. Education & Training
    • 8.1.5. Monitoring & Assessment

9. Chronic Disease Management Market - By Disease Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
    • 9.1.2. Diabetes
    • 9.1.3. Cardiovascular Diseases
    • 9.1.4. Respiratory Diseases
    • 9.1.5. Cancer
    • 9.1.6. Others

10. Chronic Disease Management Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals & Clinics
    • 10.1.3. Homecare
    • 10.1.4. Diagnostic Centers
    • 10.1.5. Payers

11. Chronic Disease Management Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Chronic Disease Management Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Chronic Disease Management Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Chronic Disease Management Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Chronic Disease Management Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Chronic Disease Management Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Chronic Disease Management Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Allscripts Healthcare Solutions, Inc.
    • 12.2.2. Altruista Health, Inc.
    • 12.2.3. Cerner Corporation
    • 12.2.4. Cognizant Technology Solutions Corporation
    • 12.2.5. Epic Systems Corporation
    • 12.2.6. GE Healthcare
    • 12.2.7. Health Catalyst, Inc.
    • 12.2.8. i2i Population Health
    • 12.2.9. IBM Corporation
    • 12.2.10. Infosys Limited
    • 12.2.11. Koninklijke Philips N.V.
    • 12.2.12. McKesson Corporation
    • 12.2.13. Medtronic plc
    • 12.2.14. Pegasystems Inc.
    • 12.2.15. Siemens Healthineers AG
    • 12.2.16. ZeOmega, Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us